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Abstract
Background: Despite the complexity of drug use, a number of indicators have been developed, standardized and
evaluated by the World Health Organization (WHO). These indicators are grouped in to three categories namely:
prescribing indicators, patient care indicators and facility indicators. The study was aimed to evaluate rational drug
use based on WHO-core drug use indicators in Dilchora referral hospital, Dire Dawa; Hiwot Fana specialized
university hospital, Harar and Karamara general hospital, Jigjiga, eastern Ethiopia.
Methods: Hospital based quantitative cross sectional study design was employed to evaluate rational drug use
based on WHO core drug use indicators in selected hospitals. Systematic random sampling for prescribing
indicators and convenient sampling for patient care indicators was employed. Taking WHO recommendations in to
account, a total of 1,500 prescription papers (500 from each hospitals) were investigated. In each hospital, 200
outpatient attendants and 30 key essential drugs were also selected using the WHO recommendation. Data were
collected using retrospective and prospective structured observational check list. Data were entered to EPI Data
Version 3.1, exported and analyzed using SPSS version 16.0. Besides, the data were evaluated as per the WHO
guidelines. Statistical significance was determined by one way analysis of variance (ANOVA) for some variables. P-value
of less than 0.05 was considered statistically significant. Finally, tabular presentation was used to present the data.
Results: Mean, 2.34 (±1.08) drugs were prescribed in the selected hospitals. Prescriptions containing antibiotics and
that of injectables were 57.87 and 10.9% respectively. The average consultation and dispensing time were 276.5 s and
61.12 s respectively. Besides, 75.77% of the prescribed drugs were actually dispensed. Only 3.3% of prescriptions were
adequately labeled and 75.7% patients know about the dosage of the prescription. Not more than, 20(66.7%) key drugs
were available in stock while only 19(63.3%) of key drugs had adequate labeling. On average, selected key drugs were
out of stock for 30 days per year. All of the hospitals included in the study used the national drug list, formulary and
standard treatment guidelines but none of them had their own drug list or guideline.
Conclusion: Majority of WHO stated core drug use indicators were not met by the three hospitals included in the study.
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Background
Rational drug use (RDU) generally covers appropriate
prescribing, appropriate dispensing and appropriate pa-
tient use of medicines for the diagnosis, prevention,
mitigation and treatment of diseases. RDU can also be
described as safe, cost-effective and economically viable
use of drugs. To ehnance RDU, the patient should re-
ceive medicines appropriate to their heath care condi-
tions, at optimum doses and sufficient time, as well as at
the cost that the individual and the community can af-
ford [1]. The ultimate goal of RDU is to foster better
quality of pharmaceutical care, to minimize the cost of
drug therapy, to avoid preventable adverse drug reac-
tions and drug interactions, to maximize therapeutic
outcomes and to promote patient adherence [2, 3].
WHO developed core and complementary drug use
indicators for evaluation of drug use in healthcare set-
tings. Among which, the core drug use indicators have
been considered as the first line indicators validated by
WHO for measurement of drug use. The core drug use
indicators are more informative, more feasible, less
likely to fluctuate over time and place as well as easier
to measure drug use than the complementary indica-
tors [4, 5]. Therefore, the core indicators have been se-
lected for better quantitative evaluation of RDU. There
are three major categories of core drug use indicators
namely, prescribing indicators (average number of
drugs per encounter; percentage of drugs prescribed
with generic name; percentage of encounters with anti-
biotics prescribed, percentage of encounters with injec-
tions prescribed and percentage of drugs prescribed
from EDL) patient care indicators (average consultation
time, average dispensing time, percentage of drugs ac-
tually dispensed, percentage of drugs actually labeled
and patient knowledge of how to take the drug), and
health facility indicators (availability of essential drugs,
availability of STGs, formularies and EDLs) [6, 7].
Pharmaceutical expenditure is up to 70/75% of total
healthcare expenditure in low and middle-income coun-
tries [8]. However, irrational use of drugs has been pri-
marily observed in healthcare systems of developing
countries. WHO estimates that more than half of all
drugs are irrationally prescribed or dispensed and more
than half of the patients fail to adhere the prescribed
regimens [5]. Common reasons for irrational use of
medicines include:- lack of adequate information about
the prescribed drugs, faulty and inadequate training of
medical graduates, poor communication between health
care providers and patients, lack of diagnostic facilities,
demand from the patient (assuming that ‘every ill has a
pill’), and defective drug supply system [9].
Irrational use of drugs can have a significant adverse
effect on health care costs, quality of pharmaceutical
care and emergence of antimicrobial resistance. Other
negative impacts are the increased risk of adverse drug
reactions, drug-drug interactions and non-adherence of
patients to the treatment [9–12].
The information available suggests medicines are not
optimally used. This inappropriate drug use has serious
health and economic influences for the success of na-
tional health care system. The irrational use of medi-
cines is a worldwide problem increasing morbidity,
mortality and costs through increasing adverse drug re-
actions and hence patients are not achieving their de-
sired outcomes [13, 14].
By and large, the causes of irrational drug use are
highly vexed and complicated involving the healthcare
system, the supply system, the health professionals, the
patient and the community at large. Considering such
problem, the overall drug use pattern should be evalu-
ated to put a baseline data for further in-depth investiga-
tion of drug use to probe the underlying causes and
interventional strategies to be implemented so as to try
and reverse worrying trends in drug utilization in
Ethiopia. Therefore, the study is, aimed to evaluate RDU
by using WHO core drug use indicators in selected pub-
lic hospitals of eastern Ethiopia.
Methods
Study design and setting
Facility based quantitative cross sectional study design was
employed to evaluate rational drug use based on WHO
core drug use indicators in the Dilchora referral hospital
(DRH), Dire Dawa; Hiwot Fana specialized University hos-
pital (HFSUH), Harar and Karamara general hospital
(KGH), Jigjiga,. The study was targeted at three tertiary
care public hospitals found in two regions and one city ad-
ministration (Dire Dawa) of eastern Ethiopia. The study
was conducted from Sep 1 to Nov 30, 2014. Retrospective
cross sectional study design was used to evaluate prescrib-
ing indicators while prospective cross-sectional design was
employed for patient care and facility indicators.
Study population
All outpatient prescriptions dispensed from Jan 1, 2014
to Jun 30, 2014 (prescribing indicators); patient atten-
dants and their prescriptions in the outpatient depart-
ments (OPDs) of selected hospitals from Sep 1 to Nov
30, 2014 (patient care indicators) and drugs under essen-
tial drug lists (EDL) of 2013 of Ethiopia were included.
However, prescriptions that contain only medical sup-
plies like glove, syringe and patient attendants outside
the normal working hours were excluded.
Sample size determination and sampling technique
For prescribing indicators
Considering WHO recommendation, 500 prescribing
encounters were taken from each corresponding hospital
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[7]. So, a total of 1,500 prescription papers were inves-
tigated in the study. A systematic random sampling
technique was employed to select 500 outpatient pre-
scriptions from each hospital by taking every ten pre-
scription in DRH, every eight in KGH and HFSUH.
Patient care indicators
Based on WHO criteria, at least 100 sample sizes of
outpatient attendants (encounters) are recommended
in individual health facility [7]. Therefore, to get a more
reliable result (greater point estimate of the population)
200 samples of patients were assessed in each hospital.
The patient attendants with their prescriptions in OPDs
were sampled by convenient sampling technique
prospectively.
For health facility indicators
Thirty key drugs were selected from each hospital as per
WHO recommendation which is a minimum of 15 es-
sential drugs in each health facility [7]. These key drugs
being used for the management of top ten diseases of
the respected hospitals were selected by communicating
with prescribers and dispensers and reviewing national
guideline.
Data collection instrument and techniques
Data were collected using structured observational check
list for prescribing, patient care and health facility indi-
cators. A reference of patient prescription papers was
used to check the patient knowledge of how to take the
correct dosage. Stop watch was used to determine the
contact time of health care providers with patient (con-
sultation and dispensing time).
Data regarding prescribing indicators were taken from
sampled prescription records retrospectively and filled in
structured check list accordingly by careful observation.
On the other hand, data regarding patient care indica-
tors was taken from patient attendants and their pre-
scriptions in OPD during the period of data collection
prospectively and was recorded in observational check
list. Among patient care indicators, data regarding pa-
tient knowledge of how to take correct dosage was
collected through face to face interview and recorded
as 1 or 0 for each patient (all-none principle) as per
the guideline. Besides, the availability of key/essential
drugs, EDL and STG was assessed in OPD, and was
filled in facility indicator form accordingly.
Data quality control
To ensure the data quality, the data collectors (pharmacy
technicians) and supervisors (pharmacists) were trained
by the principal investigators for three days. The English
version of the checklist was translated to Amharic,
Afaan Oromo and Somali languages and then back to
English to maintain its consistency for data collection
purpose. The data collection instruments were pre-
tested in Jugal hospital, Harar by two co-investigators of
the study. Completeness and consistency of the collected
data was ensured by making frequent checks on the data
collection process.
Data processing and analysis
Data was entered to EPI Data Version 3.1. Then, it was
exported and analyzed using SPSS version 16.0. Besides,
the data were evaluated as per the WHO guidelines.
Statistical significance was determined by one way ana-
lysis of variance (ANOVA) in some of the patient care
indicators. P-value less than 0.05 was considered to be
statistically significant. Finally, tabular presentation was
used to present the data.
Results
Prescribing indicators
For the assessment of WHO prescribing indicators, a
total of 1500 prescription encounters (500 in each hos-
pital) were included in the study making 100% comple-
tion and response rates. On average 2.34 (±1.08) drugs
were prescribed in selected public hospitals of eastern
Ethiopia and 39.3% of the prescription contains three or
more drugs (Table 1). Besides, from the total of 1500
prescription encounters, 3174 (90.61%) of the drugs
were prescribed by generic name with the lowest value
observed in HFSUH (85.04%) (Table 2). Amongst the
prescription encounters assessed, the study revealed
that 868 (57.87%) prescriptions contained antibiotics.
Moreover, 163 (10.9%) prescription contained at least
one injectable medication (Table 3). Amongst antibi-
otics prescribed, 44.4% of them were amoxicillin or
amoxicillin + clavulanic acid followed by ciprofloxacin
(15.4%) (Table 4).
Patient care indicators
The average consultation time and dispensing time in
selected public hospitals of eastern Ethiopia were found
to be 4.61 min and 61.12 s, respectively. Besides, on
average, only 75.77% of prescribed drugs were actually
dispensed in selected hospitals with lowest value seen in
HFSUH (69.27%) (Table 5) and among dispensed pre-
scriptions within the health facilities, only 3.3% of them
were adequately labeled in target hospitals when taken
together with zero value recorded in KGH (Table 6).
Moreover, 75.7% patients know about the correct dosage
schedule of the prescription in selected public hospitals
of eastern Ethiopia (Table 7).
Health facility indicators
Only 20(66.7%) key essential drugs were available in
stock during the study and only 19(63.3%) of key drugs
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selected had adequate labeling. On average, selected key
drugs were out of stock for 30 days per year (Table 8).
All of the hospitals included in the study use the na-
tional EDL, formulary and STGs but none of them had
their own EDLs, formularies or STGs (Table 9).
Discussion
Prescribing indicators
In this study, the average number of drug per prescrip-
tion was 2.34 (2.06–2.49) with the highest value seen in
HFSUH (2.49). The average number of drugs per pre-
scription in the present study was slightly higher than
the ideal WHO standard which is less than two (1.6–1.8)
[7]. Besides, 39.3% of prescriptions contained three or
more drugs. However, lower average numbers of medi-
cines per encounter (1.9, 1.7, 1.8, 1.8, 2.1 and 2.2) were
reported in different areas of Ethiopia such as Hawassa
University Teaching and Referral Hospital (HUTRH)
[14], southern Ethiopia [15] Jimma University Special-
ized Hospital (JUSH) [16], Dessie Referral Hospital [17],
four selected hospitals of west Ethiopia [18] and in eight
health facilities of Somali zone of eastern Ethiopia [19],
respectively. Similarly, other studies outside of Ethiopia
also reported a low number of drugs per encounter, for
example, 1.4 in Sudan [20] and 1.3 in Zimbabwe health-
care settings [21]. Most of these values will fall within
the WHO standard [7]. The degree of poly pharmacy
was the same with the result obtained from Bule Hora
Hospital, Southern Ethiopia where the average value was
found to be 2.33 [22]. On the contrary, compared to this
study, higher average number of drugs per encounter
was also reported in different areas of the world such as
2.7 and 3.7 in Indian health care settings [23, 24], 2.8 in
Nigerian army hospital [25]. Even though there are no
adequate data that identify the underlying causes of
poly-pharmacy in the study area, it might be related to
lack of adequate knowledge and training of health pro-
fessionals, variation in the health care delivery system,
empirical prescribing and symptomatic treatment ap-
proaches, differences in socioeconomic status as well as
morbidity and mortality characteristics of the population
[14]. Generally, over prescribing might, in part, be attrib-
utable to drug-drug interactions, high risk of adverse
drug reactions, wastage of drugs (extravagancy), and in-
creased out-of-pocket expenditures for patients, among
others [7].
The percentage of drugs prescribed by the generic
name was found to be 90.61% (85.04–92.26%) with the
lowest value recorded in HFSUH (85.04%). This result
was somewhat lower than the ideal WHO standard
(100%) [7]. Similarly, the current finding was lower than
the findings of Gondar University Hospital (GUH) [26]
and HUTRH [14], and health centers in Somali zone of
eastern Ethiopia [19]. However, it was higher than stud-
ies undertaken in JUSH [16] and southern Ethiopia [15].
In addition, lower values of generic prescribing practices
were recorded in several health care settings such as se-
lected hospitals of west Ethiopia (79.2%) [18], Nigerian
army hospitals (49.3%) [25], secondary care referral hos-
pital of south India (42.9%) [23]. The high level of
Table 1 Number of drugs per prescribing encounters (degree of polypharmacy) in eastern Ethiopia selected hospitals (DRH, HFSUH
and KGH), Jan 1, 2014 - Jun 30, 2014 (n = 1500)
Number of drugs DRH HFSUH KGH Overall result WHO standard
One 147(29.4) 108(21.6) 96(19.2) 351(23.4)
Two 197(39.4) 184(36.8) 178(35.6) 559(37.3)
Three 137(27.4) 116(23.2) 144(28.8) 397(26.5)
Four 17(3.4) 55(11.0) 70(14) 142(9.5)
Five 1(0.2) 25(5) 10(2) 36(2.4)
Six ____ 10(2) ____ 10(0.7)
Seven or more 1(0.2) 2(0.4) 2(0.4) 5(0.3)
Average value 2.06 (± 0.877)a 2.49 (±1.235)a 2.46 (± 1.056)a 2.34 (±1.08)b ≤ 2 (1.6–1.8)
aAverage value per hospital; boverall average number of drugs per encounter
Table 2 Percentage of drugs prescribed by generic name in DRH, HFSUH and KGH, eastern Ethiopia, Jan 1, 2014–Jun 30, 2014
(n = 1500 encounters)
Hospital name # of drugs prescribed # drugs prescribed by generic name % drugs prescribed by generic name WHO standard
DRH 1032 984 95.35a
HFSUH 1243 1057 85.04b
KGH 1228 1133 92.26a
Over all 3503 3174 90.61 100%
a Mild deviation b moderate deviation
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generic prescription could probably be attributed to the
fact that the study was conducted in governmental hos-
pitals, where procurement of generic drugs is the pre-
vailing practice. Brand prescribing is associated with
unnecessary treatment costs, difficulty of remembering
the medication, accessibility and bioequivalence prob-
lems [7]. Therefore, more effort is to be invested to ef-
fectively avoid the problems of brand prescribing and to
promote safe, cost effective and accessible generic drugs.
Percentage of prescribing encounters with antibiotic
was 57.87% (50–69.4%) which is almost twice of the
WHO standard (20–26.8%) [7]. The highest percentage
of antibiotic encounter was recorded in KGH (69.4%).
This finding was also higher than the finding of similar
studies conducted in India [27], Nigeria [25], and differ-
ent parts of Ethiopia [15–18] and almost similar with
research done in HUTRH [14]. In the medicine use
pattern study in 12 developing countries, the percentage
of encounters with antibiotic prescribed were 63% in
Sudan [20], 56% in Uganda [28], 48% in Nigeria [29] and
29% in Zimbabwe [21], among others.
Amoxicillin/amoxicillin + clavulanic acid was the most
frequently prescribed antibiotic followed by ciprofloxa-
cin. Similar study undertaken in different health care set-
tings of Ethiopia found that amoxicillin to be the most
frequently prescribed antibiotic in outpatient depart-
ments [14, 17, 19]. Inappropriate and over use of antibi-
otics, as observed in this study, might result in the
emergence of antimicrobial resistance which is one of
the major bottlenecks of chemotherapy for our globe
[7]. If irrational use of antimicrobial agents is continued
in this manner, the post antimicrobial era, where all the
existing antimicrobial agents can be historical, will be
expected in the near future. This is due to the imbalance
Table 3 Percentages of encounters with antibiotics and injections prescribed in DRH, HFSUH and KGH, eastern Ethiopia, Jan 1,
2014–Jun 30, 2014 (n = 1500)
Prescribing indicators DRH HFSHU KGH Over all WHO standard
Percentage of encounters with antibiotics Total number of encounters 500 500 500 1500
Encounters with antibiotic 271 250 347 868
% of encounters with antibiotics 52.2 50 69.4 57.87a < 30 (20–26.8%)
Percentage of encounters with injections Encounters with injections 52 93 18 163
% of encounters with injections 10.4 18.6 3.6 10.9 (13.4–21.1%)
aSignificant deviation from WHO criteria
Table 4 Antibiotics prescribed in DRH, HFSUH and KGH, eastern Ethiopia, Jan 1, 2014–Jun 30, 2014 (n = 1500)
Antibiotics Frequency (%) Over all
DRH HSUH KGH
Amoxicillin/ amoxicillin + clavulinic acid 130(42.9) 120(46.0) 165(44.5) 415(44.4)
Ciprofloxacin 40(13.2) 36(13.8) 68(18.3) 144(15.4)
Doxycycline 23(7.6) 21(8.0) 30(8.1) 74(7.9)
Norfloxacin 23(7.6) 26(10.0) 8 57(6.1)
Cotrimoxazole 7 8 30(8.1) 45(4.8)
Cloxacillin 14(4.6) 12(4.6) 12(3.2) 38(4.1)
Erythromycin 8 2 20(5.4) 30(3.2)
Benzanthine Penicillin G 10(3.3) 12(4.6) 6 28(3.0)
Chloramphenicol 7 5 13(3.5) 25(2.7)
Cephalexin 12(4.0) 5 3 20(2.1)
Clarithromycin 4 1 9 14(1.5)
Gentamicin 5 4 3 12(1.3)
Ampicillin 4 3 4 11(1.2)
Tetracycline 3 5 - 8
Tetracort 8 - - 8
Chloramphenicol eye ointment 5 - - 5
Azithromycin - 1 - 1
Total 303(100) 261(100) 371(100) 935(100)
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between alarming rate of antimicrobial resistance and
decelerating rate of new antimicrobial drug develop-
ment [7].
On average, the percentage of encounters with injec-
tions prescribed was 10.7% in the present study with a
high (18.6%) injection exposure recorded in HFSUH. In
this study, the injection practices, in the outpatient set-
tings, are generally acceptable. The current finding was
better than studies conducted in India [24] Zimbabwe
[21], southern Ethiopia [15], GUH [26] and HUTRH
[14], west Ethiopia [18] and lied within WHO standard
[7] but higher than the finding from JUSH [16]. The
lower value in this study might be due to the fact that,
as per the recommendation of WHO, only outpatient
(ambulatory) patients’ prescription was taken with a
great care so as not to overestimate the actual practice
because of addition of inpatient prescription where pre-
scribing injection is a common phenomena. Over use of
injections may be associated with unnecessary injection
related cost, risk of transmitting potential infections
through needle stick injury and physiological and psy-
chological pain during injection, difficulty of titrating
overdose [7]. Therefore, safer, cost effective and simple
oral alternatives should be promoted.
Patient care indicators
The average consultation time in this study was
4.61 min which was considered to be short (less than
10 min as per the WHO standard) [7]. The average con-
sultation time in HFSUH (6.36 min) is better than the
other hospitals involved in the study. The result was
similar to the finding of a research conducted in Eritrea
(4.7 min) [30] but lower than on time spent for
consultation in Nigeria [29]. Generally, longer consult-
ation time had improved patient satisfaction and more
effective resource use [9]. On average, 61.12 s was the
average dispensing time calculated from this study.
Time spent for dispensing was very short when com-
pared to the average dispensing time for ten countries
(105 s) [9, 31, 32] and from a similar study done in
Zimbabwe (150 s) [33] and Nigeria (210 s) [34], India
[23] and different healthcare settings of Ethiopia [19,
35]. This difference might be ascribed to variation on
patient load on the individual health care settings. Very
short dispensing time will negatively affect appropriate
labeling and information provision about medications.
Better average dispensing time was recorded in DRH.
From the prescribed medications, only 75.77% was ac-
tually dispensed: 80.25% DRH, 77.53% KGH and 69.27%
HFSUH. This finding was lower than the average of 12
countries (89%) [9, 31, 32]. The difference might be
partly ascribed to differences in the national logistic
management system. This figure indicated that patients
were prone for unnecessary medication charge by pri-
vate drug retail outlets where margin of benefit might
reach more than 100%.
Only 20 (3.3%) of medications were adequately labeled
(DRH, 9%, HFSUH, 1%, and KGH, 0%) and 75.7% of pa-
tients had adequate knowledge about the dosage of their
treatment. Patient knowledge was higher than similar
study done in Zimbabwe (70%) [33]. The patient
knowledge might look better in this study despite the
low level of labeling practice but the figure was very
low when looked at the potential impact of missing
the dosage regimen on the rest 25% patients’ health
outcome. Since the assessment of knowledge was done
Table 5 Consultation time, dispensing time and percentage of drugs actually dispensed in DRH, HFSUH and KGH, eastern Ethiopia,
Sep1-Nov 30, 2014 (n = 600)
Patient care indicators DRH HFSUH KGH Overall WHO standards P-value
Average consultation time (minute) 4.27 (±117.64) 6.36 (±266.22) 3.20(±83.88) 4.61(±191.58) 10 min P < 0.001*
Average dispensing time (Sec) 88.62(±62.56) 37.58 (±30.35) 57.16(±40.78) 61.12(±51.01) >180 s P < 0.001*
Total number of drugs prescribed 405 410 485 1300
Total number of drugs dispensed 325 284 376 985
Percentage of drugs actually dispensed 80.25 69.27 77.53 75.77 100% P < 0.001*
*One way analysis of variance (ANOVA), p value less than 0.05 was considered to be statistically significant
Table 6 Labeling status of dispensed drugs in DRH, HFSUH and KGH, eastern Ethiopia, Sep1-Nov 30, 2014 (n = 600)
Hospital
name
Contents of the label Overall
labeling statusPatient Name Drug strength Drug dosage Frequency of administration Duration of treatment
DRH 23(11.5%) 26(13.0%) 22(11.0%) 32(16.0%) 22(11.0%) 18(9.0%)a
HFSUH 4(2%) 11(5.5%) 13(6.5%) 15(7.5%) 5(2.5%) 2(1%) a
KGH 0 2(1%) 21(10.5%) 24(12.0%) 17(8.5%) 0a
Over all 27(4.5%) 39(6.5%) 56(9.3%) 71(11.8%) 44(7.3%) 20(3.3%)
a Major deviation from WHO set point
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immediately, the impact of labeling on patient know-
ledge might seem insignificant. But, their knowledge
will fade when the time elapses.
Health facility indicators
None of the hospitals involved in the current study had
its own EDL or STG. Since the prevalence of infectious
and non-infectious diseases is affected by weather condi-
tion and lifestyle of the residents, hospital level EDL and
STG are mandatory. Only 66.7% of key drugs were in
stock while 63.3% of key drugs were adequately re-
corded. The finding is much lower than a result from
Nigeria (83.3%) [36]. The absence of key drugs in stock
was a strong indicator of weak pharmacy service in the
hospitals and impair the overall services provided by the
health sectors. Lack of adequate recording might have
negatively affected the logistics management system and
prone medications for theft. The problem is highly sig-
nificant in HFSUH where none of the key drugs were
recorded and 40% of the key drugs were available in
stock. The average number of stock out days per year
for adequately recorded drugs was 30 days. Percentage
of expired drugs was 26.7% which is very significant for
a poor country like Ethiopia where majority of the
population have low access for essential drugs and ma-
jority of the drugs are imported with foreign currency
at minimum tax.
Limitation of the study
Generally, this study tried to address almost all WHO
approved core drug use indicators in selected hospitals.
These indicators highlight major problem areas of drug
use patterns and quantify the magnitude of the problem
at glance. However, they do not answer why the problem
exists. Besides, these indicators do not show whether the
drug prescribed comply with diagnosis.
Conclusion
Most of WHO stated core drug use indicators were not
met by the three hospitals included in the study. The
average number of drugs prescribed per encounter was
slightly above the WHO recommendation. Percentages
of antibiotic and injection exposure were found to be
very high. The average times spent for consultation and
dispensing were very short in all the hospitals involved
in the study. A few numbers of drugs were adequately
labeled. None of the hospitals had developed its own
EDL and STG. The recording system and stock manage-
ment were very poor, especially in HFSUH. Significant
Table 7 Patient knowledge about dosage of dispensed drugs








DRH 185(92.5%) 181(90.5%) 174(87.0%) 164(82.0%)a
HFSUH 179(89.5%) 186(93.0%) 144(72.0%) 134(67.0%)a
KGH 161(80.5%) 164(82.0%) 160(80.0%) 156(78.0%)a
Over all 525(87.5%) 531(88.5%) 478(79.7%) 454(75.7%)
a Below WHO recommendations (ideal standard)
Table 8 Key essential drugs selected in DRH, HFSUH and KGH,
eastern Ethiopia, Sep1-Nov 30, 2014 (n = 30)
Lists of key drugs DR H HFSUH KGH
Amoxicillin capsule ✓ ✓ ✓
Artemether + lumefantrine (Quartem) ✓ ✓
Ceftriaxone injection ✓ ✓
Cimetidine ✓
Chloramphenicol ✓
Ciprofloxacin tablet ✓ ✓ ✓
Cloxacillin capsule ✓
Diclofenac injection ✓ ✓











Norfloxacin tablet ✓ ✓
NPH insulin ✓
Omeprazole ✓ ✓ ✓
Oral rehydration salt (ORS) ✓
Paracetamol ✓
Regular insulin ✓
RH(Rifampin + Isoniazid) ✓ ✓








hydrocortisone and polymyxin B sulfate)
✓
Percentage of essential drugs 50a 50a 50a
WHO standard 100%
aDeviation from WHO essential drug criteria by half
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amount of key drugs were out of stock. Having this
study as a baseline data, in-depth investigation of drug
use (qualitative study) should be designed to probe the
underlying causes of the problem in these health insti-
tutions. Finally, a multitude of remedial intervention
strategies (managerial, educational, regulatory and eco-
nomical strategies) should be designed to reverse the
existing problem and modernize the drug utilization
patterns on these public health institutions and the
Ethiopian health care system in general.
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